- Home
- INIO vs SNN Comparison
INIO vs SNN Comparison
Compare INIO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INIO | SNN |
|---|---|---|
| Founded | 2018 | 1856 |
| Country | Germany | United Kingdom |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7B | 12.3B |
| IPO Year | 2026 | 2002 |
Fundamental Metrics
Financial Performance| Metric | INIO | SNN |
|---|---|---|
| Price | $14.65 | $31.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 6 |
| Target Price | $31.40 | ★ $33.19 |
| AVG Volume (30 Days) | ★ 6.8M | 1.5M |
| Earning Date | 10-27-2026 | 08-04-2026 |
| Dividend Yield | N/A | ★ 2.46% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $51.93 | $3.93 |
| Revenue Next Year | $32.90 | $4.98 |
| P/E Ratio | $126.04 | ★ $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.95 | $26.30 |
| 52 Week High | $42.95 | $37.09 |
Technical Indicators
Market Signals| Indicator | INIO | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 43.19 | 61.18 |
| Support Level | $13.76 | $31.21 |
| Resistance Level | $21.86 | $31.32 |
| Average True Range (ATR) | 1.40 | 0.58 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 28.50 | 47.76 |
Price Performance
Historical ComparisonAbout INIO INNIO N.V. Ordinary Shares
Innio NV is a distributed energy solutions provider that delivers reliable, flexible, transient, decentralized, modular, and efficient power. The group designs, manufactures, and services high-performance power systems under its Jenbacher and Waukesha brands. The company delivers power for applications including data centers, microgrids, grid stabilization, industrial energy, and gas compression.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.